Amerinet, a national healthcare group purchasing organization, has announced limited-time promotional pricing on products from Linet Americas and Graybar, according to Amerinet news releases.
Uncategorized
The Agency for Healthcare Research and Quality has released the fourth version of its Emergency Severity Index, a triage tool for emergency department personnel.
Here are 12 statistics on pain management case revenue and gross charges by region from VMG Health's Multi-Specialty ASC Intellimarker 2011. The survey included surgery centers from the West, Southwest, Midwest, Southeast and Northeast.
European researchers found frequent aspirin use increases risk of early age-related macular degeneration and more frequent aspirin use further increases risk, according to findings published in Ophthalmology.
Alfredo Dubra, PhD, assistant professor of ophthalmology and biophysics, and the Medical College of Wisconsin received a $250,000, four-year grant from Research to Prevent Blindness to study diseases impacting the retina and the optic nerve, according to a university news…
St. Jude Medical plans to more than double its Plymouth, Minn. location with a 3-floor, 275,000 square foot addition, according to a news release.
Intuitive Surgical, a global leader in minimally invasive robotic-assisted surgery, received FDA clearance to market its EndoWrist One Vessel Sealer instrument for use with the da Vinci Surgical System, according to a news release.
Hennepin County Medical Center in Minneapolis assigned pharmacists to check patients' discharge orders before they were released from the hospital and reduced its medication error rate from 92 percent to nearly zero, according to a Star Tribune report.
Advanced Pain Management, based in Greenfield, Wis., and operating nearly 40 clinics in Wisconsin and Minnesota, opened a clinic inside Aspirus Wausau Hospital, in Wausau, Wis., according to a Wausau Daily Herald report.
Endo Pharmaceuticals will pay up to $180 million, plus royalties, to BioDelivery Sciences International in a licensing and development agreement to manufacture, distribute, market and sell BEMA Buprenorphine on a global scale, according to a MarketWatch report.
